H05BX01 • cinacalcet • Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents
Cinacalcet is a medication used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of hypercalcemia associated with parathyroid carcinoma. It works by increasing the sensitivity of calcium receptors in the parathyroid glands, thereby reducing parathyroid hormone (PTH) levels.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor calcium and PTH levels.
Patients should be aware of potential side effects, such as nausea, vomiting, or hypocalcemia. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, and hypocalcemia. In rare cases, severe reactions such as seizures or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Substance: cinacalcet
Date of last drug list: 01-06-2016
Commercial code: W62641003
Concentration: 60mg
Pharmaceutical form: tablets
Quantity: 84
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).